• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

北京大学第三医院评分:一种预测根治性肾切除术和血栓切除术术中失血的综合系统。

Peking University Third Hospital score: a comprehensive system to predict intra-operative blood loss in radical nephrectomy and thrombectomy.

作者信息

Liu Zhuo, Zhao Xun, Zhang Hong-Xian, Ma Run-Zhuo, Li Li-Wei, Tang Shi-Ying, Wang Guo-Liang, Zhang Shu-Dong, Wang Shu-Min, Tian Xiao-Jun, Ma Lu-Lin

机构信息

Department of Urology, Peking University Third Hospital, Beijing 100191, China.

Health Science Center, Peking University, Beijing 100191, China.

出版信息

Chin Med J (Engl). 2020 May 20;133(10):1166-1174. doi: 10.1097/CM9.0000000000000799.

DOI:10.1097/CM9.0000000000000799
PMID:32433048
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7249704/
Abstract

BACKGROUND

Radical nephrectomy and thrombectomy is the standard surgical procedure for the treatment of renal cell carcinoma (RCC) with tumor thrombus (TT). But the estimation of intra-operative blood loss is only based on the surgeon's experience. Therefore, our study aimed to develop Peking University Third Hospital score (PKUTH score) for the prediction of intra-operative blood loss volume in radical nephrectomy and thrombectomy.

METHODS

The clinical data of 153 cases of renal mass with renal vein (RV) or inferior vena cava tumor thrombus admitted to Department of Urology, Peking University Third Hospital from January 2015 to May 2018 were retrospectively analyzed. The total amount of blood loss during operation is equal to the amount of blood sucked out by the aspirator plus the amount of blood in the blood-soaked gauze. Univariate linear analysis was used to analyze risk factors for intra-operative blood loss, then significant factors were included in subsequent multivariable linear regression analysis.

RESULTS

The final multivariable model included the following three factors: open operative approach (P < 0.001), Neves classification IV (P < 0.001), inferior vena cava resection (P = 0.001). The PKUTH score (0-3) was calculated according to the number of aforementioned risk factors. A significant increase of blood loss was noticed along with higher risk score. The estimated median blood loss from PKUTH score 0 to 3 was 280 mL (interquartile range [IQR] 100-600 mL), 1250 mL (IQR 575-2700 mL), 2000 mL (IQR 1250-2900 mL), and 5000 mL (IQR 4250-8000 mL), respectively. Meanwhile, the higher PKUTH score was, the more chance of post-operative complications (P = 0.004) occurred. A tendency but not significant overall survival difference was found between PKUTH risk score 0 vs. 1 to 3 (P = 0.098).

CONCLUSION

We present a structured and quantitative scoring system, PKUTH score, to predict intra-operative blood loss volume in radical nephrectomy and thrombectomy.

摘要

背景

根治性肾切除术联合血栓切除术是治疗伴有肿瘤血栓(TT)的肾细胞癌(RCC)的标准外科手术。但术中失血量的估计仅基于外科医生的经验。因此,我们的研究旨在开发北京大学第三医院评分(PKUTH评分),以预测根治性肾切除术联合血栓切除术中的术中失血量。

方法

回顾性分析2015年1月至2018年5月北京大学第三医院泌尿外科收治的153例伴有肾静脉(RV)或下腔静脉肿瘤血栓的肾肿物患者的临床资料。术中失血总量等于吸引器吸出的血量加上血浸纱布中的血量。采用单因素线性分析分析术中失血的危险因素,然后将显著因素纳入后续多变量线性回归分析。

结果

最终的多变量模型包括以下三个因素:开放手术方式(P<0.001)、Neves分类IV级(P<0.001)、下腔静脉切除(P = 0.001)。根据上述危险因素的数量计算PKUTH评分(0 - 3分)。随着风险评分升高,失血量显著增加。PKUTH评分0至3分的估计中位失血量分别为280毫升(四分位间距[IQR] 100 - 600毫升)、1250毫升(IQR 575 - 2700毫升)、2000毫升(IQR 1250 - 2900毫升)和5000毫升(IQR 4250 - 8600毫升)。同时,PKUTH评分越高,术后并发症发生的几率越高(P = 0.004)。PKUTH风险评分0与1至3之间总体生存差异有趋势但不显著(P = 0.098)。

结论

我们提出了一种结构化的定量评分系统,即PKUTH评分,以预测根治性肾切除术联合血栓切除术中的术中失血量。

相似文献

1
Peking University Third Hospital score: a comprehensive system to predict intra-operative blood loss in radical nephrectomy and thrombectomy.北京大学第三医院评分:一种预测根治性肾切除术和血栓切除术术中失血的综合系统。
Chin Med J (Engl). 2020 May 20;133(10):1166-1174. doi: 10.1097/CM9.0000000000000799.
2
Imaging predictors for assessment of inferior vena cava wall invasion in patients with renal cell carcinoma and inferior vena cava tumor thrombus: a retrospective study.肾细胞癌合并下腔静脉瘤栓患者下腔静脉壁侵犯评估的影像学预测因素:一项回顾性研究
Chin Med J (Engl). 2020 Sep 5;133(17):2078-2083. doi: 10.1097/CM9.0000000000000828.
3
En bloc laparoscopic radical nephrectomy with inferior vena cava thrombectomy: A single-institution experience.整块腹腔镜下根治性肾切除术联合下腔静脉取栓术:单中心经验。
Int J Urol. 2019 Mar;26(3):363-368. doi: 10.1111/iju.13873. Epub 2018 Dec 3.
4
Laparoscopic Radical Nephrectomy and Inferior Vena Cava Thrombectomy in the Treatment of Renal Cell Carcinoma.腹腔镜根治性肾切除术和下腔静脉取栓术治疗肾细胞癌。
Eur Urol. 2015 Jul;68(1):115-22. doi: 10.1016/j.eururo.2014.12.011. Epub 2014 Dec 19.
5
Nephrectomy and inferior vena cava thrombectomy for renal cell carcinoma among patients with impaired renal function: defining predictors of outcomes.肾功能受损患者肾细胞癌的肾切除术及下腔静脉血栓切除术:确定预后的预测因素
ANZ J Surg. 2016 Jan-Feb;86(1-2):44-8. doi: 10.1111/ans.13272. Epub 2015 Sep 15.
6
Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy.根治性肾切除术和下腔静脉血栓切除术对预后的影响。
Eur Urol Oncol. 2019 Nov;2(6):691-698. doi: 10.1016/j.euo.2018.10.005. Epub 2018 Nov 16.
7
[Single-center study of laparoscopic radical nephrectomy with Mayo 0-2 level inferior vena cava thrombectomy].[腹腔镜根治性肾切除术联合Mayo 0-2级下腔静脉血栓切除术的单中心研究]
Beijing Da Xue Xue Bao Yi Xue Ban. 2018 Dec 18;50(6):1053-1056.
8
Case reports of robot-assisted laparoscopic radical nephrectomy and inferior vena cava tumor thrombectomy: A retrospective analysis.机器人辅助腹腔镜根治性肾切除术和下腔静脉肿瘤血栓切除术的病例报告:回顾性分析。
Medicine (Baltimore). 2021 Aug 20;100(33):e26886. doi: 10.1097/MD.0000000000026886.
9
Treatment of renal cell carcinoma with a level III or level IV inferior vena cava thrombus using cardiopulmonary bypass and deep hypothermic circulatory arrest.采用体外循环和深低温停循环治疗伴有Ⅲ级或Ⅳ级下腔静脉血栓的肾细胞癌。
World J Surg Oncol. 2015 Apr 22;13:159. doi: 10.1186/s12957-015-0584-8.
10
Surgical complexity and prognostic outcome of small volume renal cell carcinoma with high-level venous tumor thrombus and large volume renal cell carcinoma with low-level thrombus.小体积伴高水平静脉瘤栓肾细胞癌和大体积伴低水平瘤栓肾细胞癌的手术复杂性和预后结局。
Chin Med J (Engl). 2019 Aug 5;132(15):1780-1787. doi: 10.1097/CM9.0000000000000352.

引用本文的文献

1
[Robot-assisted laparoscopic inferior vena cava segmental resection for renal tumor with tumor thrombus invading the vascular wall].机器人辅助腹腔镜下腔静脉节段性切除术治疗肿瘤血栓侵犯血管壁的肾肿瘤
Beijing Da Xue Xue Bao Yi Xue Ban. 2025 Aug 18;57(4):796-802. doi: 10.19723/j.issn.1671-167X.2025.04.027.
2
[Risk factors for massive hemorrhage after radical nephrectomy and removal of venous tumor thrombus].[根治性肾切除术及静脉瘤栓切除术后大出血的危险因素]
Beijing Da Xue Xue Bao Yi Xue Ban. 2023 Oct 18;55(5):825-832. doi: 10.19723/j.issn.1671-167X.2023.05.008.
3
T.H.R.O.B.V.S. Score - A Comprehensive Model to Predict the Surgical Complexity of Renal Cell Carcinoma With Tumor Thrombus.

本文引用的文献

1
Contrast-enhanced ultrasound in detecting wall invasion and differentiating bland from tumor thrombus during robot-assisted inferior vena cava thrombectomy for renal cell carcinoma.机器人辅助下下腔静脉癌栓取栓术中超声造影对肾细胞癌癌栓壁侵犯及良恶性的鉴别诊断价值
Cancer Imaging. 2019 Dec 2;19(1):79. doi: 10.1186/s40644-019-0265-x.
2
Surgical complexity and prognostic outcome of small volume renal cell carcinoma with high-level venous tumor thrombus and large volume renal cell carcinoma with low-level thrombus.小体积伴高水平静脉瘤栓肾细胞癌和大体积伴低水平瘤栓肾细胞癌的手术复杂性和预后结局。
Chin Med J (Engl). 2019 Aug 5;132(15):1780-1787. doi: 10.1097/CM9.0000000000000352.
3
T.H.R.O.B.V.S.评分——一种预测伴有肿瘤血栓的肾细胞癌手术复杂性的综合模型。
Front Oncol. 2022 Jun 23;12:900550. doi: 10.3389/fonc.2022.900550. eCollection 2022.
4
Inferior vena cava interruption in renal cell carcinoma with tumor thrombus: surgical strategy and perioperative results.肾细胞癌合并肿瘤栓子导致下腔静脉中断:手术策略和围手术期结果。
BMC Surg. 2021 Nov 21;21(1):402. doi: 10.1186/s12893-021-01400-2.
Diagnostic Accuracy of MRI for Detecting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma Tumor Thrombus Using Quantitative and Subjective Analysis.
MRI 对肾癌合并瘤栓患者下腔静脉壁侵犯的定量及主观分析诊断准确性研究。
AJR Am J Roentgenol. 2019 Mar;212(3):562-569. doi: 10.2214/AJR.18.20209. Epub 2018 Dec 27.
4
Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.肾细胞癌伴静脉侵犯:MRI 预测下腔静脉壁侵犯。
Cancer Imaging. 2018 May 3;18(1):17. doi: 10.1186/s40644-018-0150-z.
5
102 lumbar pedicle subtraction osteotomies: one surgeon's learning curve.102例腰椎椎弓根截骨术:一位外科医生的学习曲线
Eur Spine J. 2018 Mar;27(3):652-660. doi: 10.1007/s00586-018-5481-8. Epub 2018 Jan 30.
6
Incorporating Neutrophil-to-lymphocyte Ratio and Platelet-to-lymphocyte Ratio in Place of Neutrophil Count and Platelet Count Improves Prognostic Accuracy of the International Metastatic Renal Cell Carcinoma Database Consortium Model.将中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值纳入中性粒细胞计数和血小板计数可提高国际转移性肾细胞癌数据库联盟模型的预后准确性。
Cancer Res Treat. 2018 Jan;50(1):103-110. doi: 10.4143/crt.2017.033. Epub 2017 Mar 3.
7
Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib.全身免疫炎症指数可预测接受舒尼替尼治疗的转移性肾细胞癌患者的临床结局。
Oncotarget. 2016 Aug 23;7(34):54564-54571. doi: 10.18632/oncotarget.10515.
8
Robot-assisted Laparoscopic Inferior Vena Cava Thrombectomy: Different Sides Require Different Techniques.机器人辅助腹腔镜下下腔静脉血栓切除术:不同部位需要不同的技术。
Eur Urol. 2016 Jun;69(6):1112-9. doi: 10.1016/j.eururo.2015.12.001. Epub 2015 Dec 17.
9
EAU guidelines on renal cell carcinoma: 2014 update.EAU 指南:肾细胞癌. 2014 年更新版.
Eur Urol. 2015 May;67(5):913-24. doi: 10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21.
10
Laparoscopic management of advanced renal cell carcinoma with renal vein and inferior vena cava thrombus.腹腔镜治疗合并肾静脉和下腔静脉癌栓的晚期肾癌
Urology. 2014 Apr;83(4):812-6. doi: 10.1016/j.urology.2013.09.060. Epub 2014 Jan 8.